Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
The closing price of Novavax, Inc (NASDAQ: NVAX) was $7.68 for the day, down -0.78% from the previous closing price of $7.74. In other words, the price has decreased by -$0.78 from its previous closing price. On the day, 22.94 million shares were traded. NVAX stock price reached its highest trading level at $8.235 during the session, while it also had its lowest trading level at $7.36.
Ratios:
Our analysis of NVAX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 2.03 and its Current Ratio is at 2.06.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BTIG Research on February 28, 2025, initiated with a Buy rating and assigned the stock a target price of $19.
On July 30, 2024, JP Morgan Downgraded its rating to Underweight which previously was Neutral but kept the price unchanged to $8.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on May 19 ’25 when YOUNG JAMES F bought 10,000 shares for $7.59 per share.
YOUNG JAMES F bought 4,000 shares of NVAX for $24,406 on Apr 14 ’25. On Dec 13 ’24, another insider, King Rachel K., who serves as the Director of the company, sold 4,150 shares for $9.02 each. As a result, the insider received 37,435 and left with 14,770 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NVAX now has a Market Capitalization of 1243929600 and an Enterprise Value of 741112192. As of this moment, Novavax,’s Price-to-Earnings (P/E) ratio for their current fiscal year is 2.90, and their Forward P/E ratio for the next fiscal year is 21.55. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.04. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.99. Its current Enterprise Value per Revenue stands at 0.591 whereas that against EBITDA is 1.585.
Stock Price History:
The Beta on a monthly basis for NVAX is 2.82, which has changed by -0.510828 over the last 52 weeks, in comparison to a change of 0.11936104 over the same period for the S&P500. Over the past 52 weeks, NVAX has reached a high of $23.86, while it has fallen to a 52-week low of $5.01. The 50-Day Moving Average of the stock is 13.37%, while the 200-Day Moving Average is calculated to be -16.53%.
Shares Statistics:
NVAX traded an average of 7.95M shares per day over the past three months and 21162500 shares per day over the past ten days. A total of 161.96M shares are outstanding, with a floating share count of 147.60M. Insiders hold about 8.87% of the company’s shares, while institutions hold 56.73% stake in the company. Shares short for NVAX as of 1745971200 were 42333778 with a Short Ratio of 5.32, compared to 1743379200 on 36878298. Therefore, it implies a Short% of Shares Outstanding of 42333778 and a Short% of Float of 26.229998.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
